Ocera Therapeutics (OCRX1)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Linda S. Grais
Employees:
19
555 TWIN DOLPHIN DRIVE, SUITE 615, REDWOOD CITY, CA 94065
6504750158

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Ocera Therapeutics, Inc. is a clinical stage biopharmaceutical company. It engages in development and commercialization of OCR-002 (ornithine phenylacetate0 in intravenous and oral formulations. The company was founded by Wu Xiaoyun, John C. Kappes, and Eckard Weber on January 12, 1998 and is headquartered in Palo Alto, CA.

Data derived from most recent annual or quarterly report
Market Cap 47.46 Million Shares Outstanding26.514 Million Avg 30-day Volume 371.716 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.24
Price to Revenue59.0354 Debt to Equity1.9176 EBITDA-24.238 Million
Price to Book Value7.8611 Operating Margin-4552.7344 Enterprise Value23.247 Million
Current Ratio1.274 EPS Growth0.289 Quick Ratio1.222
1 Yr BETA 1.0222 52-week High/Low 0.0 / Profit Margin-4733.9844
Operating Cash Flow Growth4.1991 Altman Z-Score-19.2392 Free Cash Flow to Firm -17.149 Million
View SEC Filings from OCRX1 instead.

View recent insider trading info

Funds Holding OCRX1 (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding OCRX1 BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

DOMAIN ASSOCIATES

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

VITULLO NICOLE

HALAK BRIAN K

KAMDAR KIM P.

  • 10% Owner
No longer subject to file 2017-12-11 0

DOMAIN PARTNERS VI, L.P.

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

VITULLO NICOLE

  • 10% Owner
No longer subject to file 2017-12-11 0

DP VI ASSOCIATES, L.P.

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

VITULLO NICOLE

  • 10% Owner
No longer subject to file 2017-12-11 0

DP VIII ASSOCIATES, L.P.

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

VITULLO NICOLE

HALAK BRIAN K

  • 10% Owner
No longer subject to file 2017-12-11 0

DOMAIN PARTNERS VIII, L.P.

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

VITULLO NICOLE

HALAK BRIAN K

  • 10% Owner
No longer subject to file 2017-12-11 0

VANLENT ANNE

  • Director
0 2017-12-11 0

WIERENGA WENDALL

  • Director
0 2017-12-11 0

JAMES STEVEN P

  • Director
0 2017-12-11 0

WEBER ECKARD

  • Director
0 2017-12-11 0

DERE WILLARD H

  • Director
0 2017-12-11 0

KJELLSON NINA S

  • Director
0 2017-12-11 0

GRAIS LINDA S PRESIDENT AND CEO

  • Officer
  • Director
0 2017-12-11 0

BYRNES MICHAEL CFO AND TREASURER

  • Officer
0 2017-12-11 0

BUKOFZER STAN CHIEF MEDICAL OFFICER

  • Officer
0 2017-12-11 0

THOMAS MCNERNEY & PARTNERS LP

TMP ASSOCIATES LP

TMP NOMINEE, LLC

THOMAS, MCNERNEY & PARTNERS, LLC

THOMAS, MCNERNEY & PARTNERS II L.P.

TMP ASSOCIATES II LP

TMP NOMINEE II, LLC

THOMAS, MCNERNEY & PARTNERS II, LLC

THOMAS JAMES E

  • 10% Owner
No longer subject to file 2017-01-30 0

POWELL MICHAEL

  • Director
0 2016-12-31 0

AGGARWAL GAURAV CHIEF BUSINESS OFFICER

  • Officer
20,000 2016-01-15 0

PATNI RAJIV CHIEF DEVELOPMENT OFFICER

  • Officer
5,050 2015-05-07 0

SHAH NIMESH

  • 10% Owner
47,963 2015-01-01 0

TETLOW SHARON ACTING CFO & TREASURER

  • Officer
3,000 2014-07-11 0

EKMAN LARS

  • Director
0 2014-06-11 0

CASTAIGNE JEAN-PAUL

  • Director
0 2014-06-11 0

SOFINNOVA VENTURE PARTNERS VI L P

SOFINNOVA VENTURE PARTNERS VI GMBH & CO. KG

SOFINNOVA VENTURE AFFILIATES VI LP

SOFINNOVA MANAGEMENT VI, L.L.C.

BUATOIS ERIC

AZAN ALAIN

HEALY JAMES

  • 10% Owner
No longer subject to file 2014-03-18 0

ROUSSEAU FRANCK CHIEF MEDICAL & DEV OFFICER

  • Officer
  • Director
0 2013-12-19 0

HILLEMAN JERYL L CFO AND SECRETARY

  • Officer
0 2013-12-19 0

SHAH PRATIK

  • Director
0 2013-12-19 0

TREU JESSE I

  • 10% Owner
1,629,157 2013-07-15 0

DOMAIN ASSOCIATES

  • 10% Owner
47,963 2013-07-15 0

BLAIR JAMES C

  • 10% Owner
1,588,857 2013-07-15 0

VITULLO NICOLE

  • 10% Owner
1,629,157 2013-07-15 0

THOMAS MCNERNEY & PARTNERS LP

TMP NOMINEE, LLC

TMP ASSOCIATES LP

THOMAS, MCNERNEY & PARTNERS, LLC

THOMAS JAMES E

MCNERNEY PETE

ZISSON ALEX

SHAH PRATIK

AGUIAR ERIC

  • Director
  • 10% Owner
2,438,569 2013-07-15 0

DOVEY BRIAN H

  • 10% Owner
1,629,157 2013-07-15 0

SCHOEMAKER KATHLEEN K

  • 10% Owner
1,629,157 2013-07-15 0

THOMAS, MCNERNEY & PARTNERS II L.P.

TMP NOMINEE II, LLC

TMP ASSOCIATES II LP

AGUIAR ERIC

  • 10% Owner
2,438,569 2013-07-15 0

DOMAIN PARTNERS VI, L.P.

  • 10% Owner
1,565,463 2013-07-15 0

DP VI ASSOCIATES, L.P.

  • 10% Owner
15,731 2013-07-15 0

HALAK BRIAN K

  • 10% Owner
1,629,157 2013-07-15 0

THOMAS, MCNERNEY & PARTNERS II L.P.

TMP NOMINEE II, LLC

TMP ASSOCIATES II LP

THOMAS, MCNERNEY & PARTNERS II, LLC

  • 10% Owner
2,438,569 2013-07-15 0

DP VIII ASSOCIATES, L.P.

  • 10% Owner
7,333 2013-07-15 0

DOMAIN PARTNERS VIII, L.P.

  • 10% Owner
988,285 2013-07-15 0

ZISSON ALEX

  • FORMERLY A DIRECTOR
No longer subject to file 2013-07-15 0

KAMDAR KIM P.

  • 10% Owner
47,963 2013-07-15 0

MCGOWAN DANA S. CFO AND SECRETARY

  • Officer
0 2013-07-15 0

STANLEY RHONDA L. CONTROLLER

  • Officer
0 2013-01-04 0

JOHNSON JOHN

  • Director
0 2012-08-07 0

ABERCROMBIE GEORGE B

  • Director
0 2012-08-07 0

THOMAS HELMUT SENIOR VP, R&D

  • Officer
0 2012-08-07 0

EISENSTADT RICHARD I VP, FINANCE & CFO

  • Officer
0 2012-08-07 0

GARG VIPIN K PRESIDENT & CEO

  • Officer
  • Director
0 2012-08-07 0

DAVIDSON AARON

  • Director
0 2012-08-07 0

MOORE DAVID VP, COMMERCIAL OPERATIONS

  • Officer
0 2012-04-19 0

BAKER BIOTECH CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • 10% Owner
232,011 2012-03-12 0

BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC

BAKER FELIX

BAKER JULIAN

  • 10% Owner
2,328,863 2012-03-12 0

14159 CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • 10% Owner
57,704 2012-03-12 0

GAVIN BRENDA D

  • Director
0 2011-04-19 0

KOSUTIC GORDANA VP, CLINICAL AND REGULATORY

  • Officer
0 2011-04-19 0

H.I.G. VENTURES - TRANZYME, LLC

HIG GP II INC

MNAYMNEH SAMI

TAMER ANTHONY

DAVIDSON AARON

  • Director
  • 10% Owner
3,002,291 2011-04-06 0

QUAKER BIO VENTURES LP

QUAKER BIOVENTURES CAPITAL LP

GAVIN BRENDA D

  • Director
  • 10% Owner
2,564,791 2011-04-06 0

THOMAS MCNERNEY & PARTNERS LP

TMP NOMINEE, LLC

TMP ASSOCIATES LP

THOMAS, MCNERNEY & PARTNERS, LLC

THOMAS JAMES E

MCNERNEY PETE

ZISSON ALEX

  • Director
  • 10% Owner
3,002,286 2011-04-06 0

BDC CAPITAL INC.

  • 10% Owner
No longer subject to file 2011-04-06 0

CAPITAL REGIONAL ET COOPERATIF DESJARDINS

DESJARDINS-INNOVATECH S.E.C.

  • 10% Owner
No longer subject to file 2011-04-06 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments